Home > Boards > US Listed > Medical - Drugs > ISTA Pharmaceuticals Inc. (ISTA)

1:26AM ISTA Pharm issues upside FY09 revenue guidance

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
surf1944 Member Profile
 
Followed By 436
Posts 25,100
Boards Moderated 5
Alias Born 09/11/06
160x600 placeholder
surf1944   Tuesday, 02/02/10 08:56:36 AM
Re: None
Post # of 69 
1:26AM ISTA Pharm issues upside FY09 revenue guidance (ISTA) 3.74 : Co issues upside guidance for FY09 (Dec), sees FY09 (Dec) revs of $110.6 mln vs. $108.60 mln First Call consensus. Growth of its Xibrom 0.09% and Istalol 0.5% franchises, in addition to initial orders for ISTA's treatment for allergic conjunctivitis, Bepreve 1.5%, led to the 33% increase in revenue as compared to 2008 net revenue.


surf's up......crikey



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist